SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs

CONCLUSION: Class III antiarrhythmic drugs are potential inhibitors of ORF 3a-mediated currents, offering new options for the treatment of COVID-19-related cardiac …